Portfolio

EQT VIII

Investments range between EUR 150 million and EUR 1,000 million

EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.

EQT Fund Management S.à r.l.
26A Boulevard Royal
L-2449, Luxembourg
Luxembourg

Company Registration Number: RCS B 167 972

EQT Fund Management S.à r.l. is an alternative investment fund manager authorized and regulated in accordance with the Luxembourg law of 12 July 2013.

Fast facts

  • Status
    Fully invested
  • Launch
    2018
  • Status
    EUR 10.91 bn

Board of directors

Investment advisory committee

  • Advisor
    Claes Dahlbäck
  • Advisor
    Massimo Rossi
  • Karo Pharma
  • SHL Medical
  • Recover
  • Schülke
  • Aldevron
  • Banking Circle
  • Facile
  • IFS
  • Azelis
  • Cast & Crew
  • Igenomix
  • Waystar
  • WS Audiology
  • Dellner Couplers
  • SUSE
  • Galderma

Type of commitments

By region

25%Rest of Europe
24%North America
23%Nordic
20%Asia Pacific
8%Rest of the world

By type

36%Pension fund
32%Financial/other
15%Sovereign wealth funds
11%Fund-of-funds/gatekeepers
6%Endowments/foundation/family offices
EQT logo

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2021. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180